Market Publishers Ltd and Black Swan Analysis Sign Partnership Agreement

17 September 2015  •  Author: Black Swan

Market Publishers Ltd and Black Swan Analysis signed a partnership agreement for quality market research promotion on the Internet. is now authorised to distribute and sell research reports elaborated by Black Swan Analysis.

Commenting on the partnership agreement, Natalie Aster, Assistant Manager at Partners Department, noted: “Black Swan Analysis is aimed at delivering top-quality data analysis, epidemiology data, forecast modeling and market research across the healthcare industry. The company is well positioned to assist any healthcare or pharmaceutical organisation in analysing and identifying the potential value of their assets. Black Swan Analysis grants unrivalled access to their proprietary pricing and disease epidemiology online database and reports, targeted to equipping clients with insightful information and data to evaluate a disease area or commercialise their products, make the right business decisions and attain their financial goals.” Furthermore, she added: “We look to building strong and long-term relationships with Black Swan Analysis, which also cannot but bring positive results to our manifold clients worldwide.”

New Comprehensive Reports by Black Swan Analysis:

Epiomic Epidemiology Series: Hypertrophic Cardiomyopathy Forecast in 8 Major Markets 2015-2025. The report provides the current prevalent population for hypertrophic cardiomyopathy (HCM) across the top 8 markets – the USA, Germany, France, Italy, the UK, Spain, Japan and Brazil; split by 5-year age cohort and gender. In tandem with the present-day prevalence, the study provides an in-depth overview of the types, occlusion locations and the prevalence of related disorders of HCM. The research publication also contains a disease overview of the risk factors, disease diagnosis and prognosis alongside specific variations based on ethnicity and geography. A number of the key symptoms and co-morbidities of HCM are quantified and presented coupled with the overall prevalence data. These sub-populations within the major disease are also examined and forecast at a national level.

Epiomic Epidemiology Series: Huntington’s Disease Forecast in 8 Major Markets 2015-2025. Huntington’s disease (HD) is an inherited autosomal dominant condition, leading to a deteriorative disorder of the human nervous system. This disease often begins in the middle age and is related to the duration of survival. The research study provides quantitative data on the patient populations in the global HD market, which helps target the development of prospective products, pricing strategies and launch plans. It gives insights into the prevalence of HD and identifies patient segments with high potential; presents accurate information on clinical studies and realistic patient recruitment for different countries; provides a deeper understanding of the degree of influence from specific comorbid conditions on the HD prevalent population, etc.

Epiomic Epidemiology Series: Retinal Vein Occlusion Forecast in 8 Major Markets 2015-2025. Retinal vein occlusion (RVO) is a common vascular disease of the retina and is one of the most common causes of blindness from pole to pole. The report provides the current prevalent population for the diesease across the markets of the USA, France, Italy, Germany, the UK, Brazil, Spain and Japan; broken down by gender and 5-year age cohort. The research report provides a deep overview of the types, occlusion locations and the prevalence of pertinent disorders of RVO. The report also contains an overview of the risk factors, diagnosis and prognosis for the disorder along with certain variations according to geography and ethnicity.

Comments are closed.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...